Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
The Cannabist Company has closed the sale of its Virginia cannabis business to an entity affiliated with Millstreet Credit Fund LP for total consideration of $130 million. The Virginia assets include five active retail locations, one additional retail location in development, and about 82,000 square feet of cultivation and production capacity in the Richmond region.
Total consideration consists of $117.5 million paid in cash at closing and $12.5 million held in an offset escrow amount. The escrow will be released in two parts, including up to $1 million after finalization of a post-closing purchase price adjustment and the remainder after the nine-month anniversary, subject to indemnification obligations.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026